How many Exelon (EXC) phantom share equivalents does Matthew C. Rogers now hold?

After the reported grant, Matthew C. Rogers holds 1,524 deferred phantom share equivalents. This balance includes 7 additional equivalents that accrued automatically through dividend reinvestment in the Exelon stock fund.

What are deferred phantom share equivalents at Exelon (EXC)?

Deferred phantom share equivalents are bookkeeping units whose value tracks Exelon common stock. For Matthew C. Rogers, they are held in a non-qualified deferred compensation plan and are settled in cash on a 1-for-1 basis when his board service ends.

How are Matthew C. Rogers’ Exelon (EXC) phantom share equivalents settled?

Matthew C. Rogers’ deferred phantom share equivalents will be settled in cash on a 1-for-1 basis. Settlement occurs upon the termination of his service on Exelon’s board of directors, according to the plan terms.

Exelon (EXC) director Matthew C. Rogers granted 778 deferred phantom share units

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Exelon Corp director Matthew C. Rogers received a grant of deferred phantom share equivalents as part of his compensation. On the transaction date, he acquired 778 deferred phantom share equivalents tied to Exelon common stock at a reference price of $46.62 per share. These units are held in his Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis when his board service ends. After this grant and dividend-related accruals, his balance in this plan totals 1,524 phantom share equivalents, including 7 units added through automatic dividend reinvestment.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rogers Matthew C

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred phantom share equivalents	778	$46.62	$36K

Holdings After Transaction: Deferred phantom share equivalents — 1,524 shares (Direct, null)

Footnotes (1)

Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors. Balance includes 7 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Key Figures

Phantom share equivalents granted: 778 units Reference price per unit: $46.62 per share equivalent Total phantom share equivalents after grant: 1,524 units +2 more

5 metrics

Phantom share equivalents granted 778 units Deferred phantom share equivalents grant to director

Reference price per unit $46.62 per share equivalent Value used for the phantom share grant

Total phantom share equivalents after grant 1,524 units Balance following the transaction

Dividend reinvestment accrual 7 units Additional phantom share equivalents from automatic dividend reinvestment

Settlement type Cash, 1-for-1 with common stock Settlement upon termination of board service

Key Terms

Deferred phantom share equivalents, non-qualified deferred compensation plan, automatic dividend reinvestment

3 terms

non-qualified deferred compensation plan financial

"part of a multi-fund, non-qualified deferred compensation plan"

An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.

automatic dividend reinvestment financial

"accrued to the account through automatic dividend reinvestment"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 04:38 PM Accepted by SEC EDGAR 07/01/2026 - 04:37 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rogers Matthew C

(Last)

(First)

(Middle)

10 S DEARBORN STREET

54TH FLOOR

(Street)

CHICAGO

ILLINOIS

60603

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred phantom share equivalents	⁽¹⁾	06/30/2026		A		778		⁽¹⁾	⁽¹⁾	Common Stock	778	$46.62	1,524⁽²⁾	D

Explanation of Responses:

1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.

2. Balance includes 7 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Remarks:

	David T Skinner, attorney-in-fact for Matthew C Rogers	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Exelon (EXC) director Matthew C. Rogers report?

Matthew C. Rogers reported receiving a grant of 778 deferred phantom share equivalents. These are compensation-related units tied to Exelon common stock value, not an open-market stock purchase or sale.

Was the Exelon (EXC) Form 4 transaction a stock market purchase or sale?

No. The Form 4 shows a grant of 778 deferred phantom share equivalents to Matthew C. Rogers as compensation. It was not an open-market stock purchase or sale of Exelon common shares.